Jocelyn Laporte (PhD) is an INSERM research director leading a team at the IGBMC in Illkirch, France. He is focusing on understanding and treating neuromuscular diseases. He completed a PhD in molecular biology with Prof. Jean-Louis Mandel (IGBMC, Strasbourg University, 1997) where he identified the first gene implicated in myotubular/centronuclear myopathies. He was recruited by INSERM in 1998 and created a research team in 2007 at IGBMC. With his co-workers, they have identified 15 genes implicated in human genetic diseases, and now focus on severe congenital myopathies to tackle their genetic basis and pathological mechanisms, and to validate therapeutic proof-of-concept. The team uses integrated and multi-disciplinary approaches and decipher skeletal muscle functions both under normal and pathological conditions, generating novel knowledge with impact on basic science and translational medicine. Jocelyn published more than 130 publications in peer-reviewed journals and participated to the mentoring of 19 PhD students. Jocelyn is cofounder and scientific advisor of Dynacure.